Filing Flows › HeartSciences (HSCS) › Q2 FY26
HeartSciences (HSCS) Q2 FY26 earnings results (second quarter fiscal 2026)
10-Q filed Dec 15, 2025
HeartSciences (HSCS) reported revenue of $2K for the second quarter fiscal 2026 (Q2 FY26) and +27% from the quarter before.
HeartSciences, Q2 FY26: revenue $2K, net loss $2.4M, operating cash flow −$2.3M. The chart follows the revenue to costs, profit and cash.
| Q2 FY26 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2K | +27% | — |
| Operating profit | −$2.1M | — | — |
| Net earnings | −$2.4M | — | — |
| Operating cash flow | −$2.3M | — | — |
What changed
Revenue was $2K in Q2 FY26, up 27% from the previous quarter.
Gross margin was 58.3%. Operating costs exceeded revenue by $2.1M, an operating margin of -85713.2%. The quarter ended with a net loss of $2.4M, wider than the previous quarter's $2.1M loss.
Operating cash flow was −$2.3M. Non-cash charges added back $7K of depreciation and $437K of share-based compensation. Working capital and other items used $427K.
Questions
What was HeartSciences' revenue in the second quarter fiscal 2026?
HeartSciences (HSCS) reported revenue of $2K for the second quarter fiscal 2026 (Q2 FY26) and +27% from the quarter before.
Source: HeartSciences 10-Q on SEC EDGAR.